| [1] |
Cai Y, Chai Y, Fu Y, et al. Salidroside ameliorates Alzheimer's disease by targeting NLRP3 inflammasome-mediated pyroptosis[J]. Front Aging Neurosci, 2022, 13:809433.
|
| [2] |
Oladapo A, Jackson T, Menolascino J, et al. Role of pyroptosis in the pathogenesis of various neurological diseases[J]. Brain Behav Immun, 2024, 117:428-446.
|
| [3] |
Moonen S, Koper MJ, van Schoor EV, et al. Pyroptosis in Alzheimer's disease: Cell type-specific activation in microglia, astrocytes and neurons[J]. Acta Neuropathol, 2023, 145(2):175-195.
|
| [4] |
Ju Y, Zhao L, Li S, et al. The role of pyroptosis in Alzheimer's disease[J]. J Integr Neurosci, 2023, 22(5):129.
|
| [5] |
Zhou J, Qiu J, Song Y, et al. Pyroptosis and degenerative diseases of the elderly[J]. Cell Death Dis, 2023, 14(2):94.
|
| [6] |
Huang Y, Li X, Luo G, et al. Pyroptosis as a candidate therapeutic target for Alzheimer's disease[J]. Front Aging Neurosci, 2022, 14:996646.
|
| [7] |
Liu Z, Wang C, Lin C. Pyroptosis as a double-edged sword: The pathogenic and therapeutic roles in inflammatory diseases and cancers[J]. Life Sci, 2023, 318:121498.
|
| [8] |
Wang T, Long Q, Hu Y, et al. miR-181c-5p suppresses neuronal pyroptosis via NLRP1 in Alzheimer's disease[J]. Behav Brain Res, 2023, 447:114387.
|
| [9] |
Gong W, Shi Y, Ren J. Research progresses of molecular mechanism of pyroptosis and its related diseases[J]. Immunobiology, 2020, 225(2):151884.
|
| [10] |
Wei Y, Yang L, Pandeya A, et al. Pyroptosis-induced inflammation and tissue damage[J]. J Mol Biol, 2022, 434(4):167301.
|
| [11] |
Li Y, Jiang Q. Uncoupled pyroptosis and IL-1β secretion downstream of inflammasome signaling[J]. Front Immunol, 2023, 14:1128358.
|
| [12] |
Yu P, Zhang X, Liu N, et al. Pyroptosis: Mechanisms and diseases[J]. Signal Transduct Target Ther, 2021, 6(1):128.
|
| [13] |
Zhang J, Wirtz S. Does pyroptosis play a role in inflammasome-related disorders[J]? Int J Mol Sci, 2022, 23(18):10453.
|
| [14] |
Rao Z, Zhu Y, Yang P, et al. Pyroptosis in inflammatory diseases and cancer[J]. Theranostics, 2022, 12(9):4310-4329.
|
| [15] |
Hou J, Li T, Hsu JM, et al. Gasdermins and cancers[J]. Semin Immunol, 2023, 70:101833.
|
| [16] |
Imre G. Pyroptosis in health and disease[J]. Am J Physiol Cell Physiol, 2024, 326(3):C784-C794.
|
| [17] |
Cao Q, Zhang JB, Sun DY, et al. Pyroptosis, metabolism, and oxidation in tumorigenesis: mechanisms and therapeutic implications[J]. Antioxid Redox Signal, 2023, 39(7-9):512-530.
|
| [18] |
Huang H, Weng Y, Tian W, et al. Molecular mechanisms of pyroptosis and its role in anti-tumor immunity[J]. Int J Biol Sci, 2023, 19(13):4166-4180.
|
| [19] |
Coll RC, Schroder K, Pelegrín P. NLRP3 and pyroptosis blockers for treating inflammatory diseases[J]. Trends Pharmacol Sci, 2022, 43(8):653-668.
|
| [20] |
Xu W, Huang Y, Zhou R. NLRP3 inflammasome in neuroinflammation and central nervous system diseases[J]. Cell Mol Immunol, 2025, 22(4):341-355.
|
| [21] |
Cheng J, Zhao H. NEK7 induces lactylation in Alzheimer's disease to promote pyroptosis in BV-2 cells[J]. Mol Brain, 2024, 17(1):81.
|
| [22] |
Huang C, Li J, Zhang C. What role does pyroptosis play in cancer?[J]. Mol Metab, 2022, 65:101587.
|
| [23] |
Rajesh Y, Kanneganti TD. Innate immune cell death in neuroinflammation and Alzheimer's disease[J]. Cells, 2022, 11(12):1885.
|
| [24] |
Mangalmurti A, Lukens JR. How neurons die in Alzheimer's disease: Implications for neuroinflammation[J]. Curr Opin Neurobiol, 2022, 75:102575.
|
| [25] |
Hu B, Zhang J, Huang J, et al. NLRP3/1-mediated pyroptosis: Beneficial clues for the development of novel therapies for Alzheimer's disease[J]. Neural Regen Res, 2024, 19(11):2400-2410.
|
| [26] |
Yeerlan J, He B, Hu X, et al. Global research trends and hotspots for ferroptosis, necroptosis, and pyroptosis in Alzheimer's disease from the past to 2023: A combined bibliometric review[J]. J Alzheimers Dis Rep, 2024, 8(1):129-142.
|
| [27] |
Xia P, Ma H, Chen J, et al. Differential expression of pyroptosis-related genes in the hippocampus of patients with Alzheimer's disease[J]. BMC Med Genomics, 2023, 16(1):56.
|
| [28] |
Song T, Chen Y, Li C, et al. Identification of molecular correlations of GSDMD with pyroptosis in Alzheimer's disease[J]. Comb Chem High Throughput Screen, 2024, 27(14):2125-2139.
|
| [29] |
Xue W, Cui D, Qiu Y. Research progress of pyroptosis in Alzheimer's disease[J]. Front Mol Neurosci, 2022, 15:872471.
|
| [30] |
Wang Q, Guo S, Hu D, et al. Enhanced gasdermin-E-mediated pyroptosis in Alzheimer's disease[J]. Neuroscience, 2024, 536:1-11.
|
| [31] |
López-Hernández R, de la Torre-álamo MM, García-Bueno B, et al. Inflammasomes in Alzheimer's progression: Nrf2 as a preventive target[J]. Antioxidants (Basel), 2025, 14(2):121.
|
| [32] |
Xie Z, Li L, Hou W, et al. Critical role of Oas1g and STAT1 pathways in neuroinflammation: Insights for Alzheimer's disease therapeutics[J]. J Transl Med, 2025, 23(1):182.
|
| [33] |
Ding Y, Li SY, Lv W, et al. Pyroptosis signature gene CHMP4B regulates microglia pyroptosis by inhibiting GSDMD in Alzheimer's disease[J]. Mol Neurobiol, 2025, 62(1):77-90.
|
| [34] |
Zhang Z, Bai J, Zhang S, et al. The relationship between Alzheimer's disease and pyroptosis and the intervention progress of traditional Chinese medicine[J]. Int J Gen Med, 2024, 17:4723-4732.
|
| [35] |
Zhuang GD, Deng SM, Chen MD, et al. Huang-Lian-Jie-Du Decoction alleviates diabetic encephalopathy by regulating inflammation and pyroptosis via suppression of AGEs/RAGE/NF-kappaB pathways[J]. J Ethnopharmacol, 2025, 337(Pt 1):118787.
|
| [36] |
Shao N, Ding Z, Liu F, et al. Huang-Pu-Tong-Qiao formula alleviates hippocampal neuron damage by inhibiting NLRP3 inflammasome-mediated pyroptosis in Alzheimer's disease[J]. Mol Neurobiol, 2025, 62(4):4545-4561.
|
| [37] |
Lee S, Cho HJ, Ryu JH. Innate immunity and cell death in Alzheimer's disease[J]. ASN Neuro, 2021, 13:17590914211051908.
|
| [38] |
Xu P, Li F, Tang H. Pyroptosis and airway homeostasis regulation[J]. Physiol Res, 2023, 72(1):1-13.
|
| [39] |
Ma J, Tian Y, Du C, et al. Cerium-doped Prussian blue biomimetic nanozyme as an amplified pyroptosis inhibitor mitigate Aβ oligomer-induced neurotoxicity in Alzheimer's disease[J]. J Nanobiotechnology, 2025, 23(1):181.
|
| [40] |
Li Y, Yang C, Liu X, et al. Potential therapeutic targets for Alzheimer's disease: Fibroblast growth factors and their regulation of ferroptosis, pyroptosis and autophagy[J]. Neuroscience, 2025, 573:42-51.
|
| [41] |
DingY, Liu Y, Li D, et al. Melatonin ameliorates senescence of mouse auditory cell line HEI-OC1 cells by suppressing NLRP3 inflammasome-mediated pyroptosis[J]. Mol Neurobiol, 2025, 62(8):9902-9915.
|